MBX Biosciences, Inc. (MBX)
49.55
-3.86
(-7.23%)
USD |
NASDAQ |
Nov 20, 16:00
49.60
+0.05
(+0.10%)
After-Hours: 20:00
MBX Biosciences Total Return Level : 49.55 for Nov. 20, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 20, 2026 | 49.55 |
| November 19, 2026 | 53.41 |
| November 18, 2026 | 53.42 |
| November 17, 2026 | 53.10 |
| November 16, 2026 | 53.12 |
| November 13, 2026 | 55.94 |
| November 12, 2026 | 54.51 |
| November 11, 2026 | 57.72 |
| November 10, 2026 | 56.33 |
| November 09, 2026 | 54.06 |
| November 06, 2026 | 51.35 |
| November 05, 2026 | 48.46 |
| November 04, 2026 | 52.48 |
| November 03, 2026 | 55.00 |
| November 02, 2026 | 54.40 |
| October 30, 2026 | 55.87 |
| October 29, 2026 | 54.54 |
| October 28, 2026 | 54.16 |
| October 27, 2026 | 52.97 |
| October 26, 2026 | 50.29 |
| October 23, 2026 | 48.50 |
| October 22, 2026 | 50.46 |
| October 21, 2026 | 53.93 |
| October 20, 2026 | 53.50 |
| October 19, 2026 | 52.48 |
| Date | Value |
|---|---|
| October 16, 2026 | 49.61 |
| October 15, 2026 | 50.71 |
| October 14, 2026 | 48.82 |
| October 13, 2026 | 49.00 |
| October 12, 2026 | 52.02 |
| October 09, 2026 | 53.24 |
| October 08, 2026 | 53.25 |
| October 07, 2026 | 54.54 |
| October 06, 2026 | 56.92 |
| October 05, 2026 | 58.54 |
| October 02, 2026 | 58.51 |
| October 01, 2026 | 56.55 |
| September 30, 2026 | 58.62 |
| September 29, 2026 | 57.75 |
| September 28, 2026 | 57.54 |
| September 25, 2026 | 53.63 |
| September 24, 2026 | 55.39 |
| September 23, 2026 | 57.89 |
| September 22, 2026 | 61.98 |
| September 21, 2026 | 60.94 |
| September 18, 2026 | 62.91 |
| September 17, 2026 | 63.89 |
| September 16, 2026 | 61.57 |
| September 15, 2026 | 61.08 |
| September 14, 2026 | 59.49 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Ligand Pharmaceuticals, Inc. | 381.71 |
| Xeris Biopharma Holdings, Inc. | 16.97 |
| ANI Pharmaceuticals, Inc. | 68.55 |
| Corcept Therapeutics, Inc. | 63.62 |
| Veru, Inc. | 2.268 |